Editorial: The Impact of Angiogenic Growth Factors and Hypoxia on the Antitumor Immune Response

Front Immunol. 2022 Apr 19:13:903105. doi: 10.3389/fimmu.2022.903105. eCollection 2022.

Loredana Albonici¹, Sara Labiano Almiñana^{2

3

4}, Toshihide Tanaka⁵, Roberto Bei¹

¹ Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
² Department of Pediatrics, Clinica Universidad de Navarra, Health Research Institute of Navarra (IDISNA), Pamplona, Spain.
³ Program in Solid Tumors, Foundation for the Applied Medical Research, Pamplona, Spain.
⁴ Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.
⁵ Department of Neurosurgery, Jikei University School of Medicine Kashiwa Hospital, Kashiwa-shi, Japan.

No abstract available

Keywords: TME (tumor microenvironment); angiogenic growth factors; anti-tumor innate immune cell; antitumor adaptive immune cells; hypoxia.

Publication types